期刊文献+

藤茶提取物通过PI3K/Akt/Bcl-2途径抑制人前列腺癌LNCaP细胞增殖的机制研究 被引量:3

Mechanism research on the proliferation inhibition of human prostate cancer cells LNCaP by Tengcha extract with PI3K/Akt/Bcl-2 pathway
下载PDF
导出
摘要 目的探讨藤茶提取物对人前列腺癌细胞LNCaP细胞增殖抑制的作用机制。方法 LNCaP细胞分为对照组、藤茶提取物不同浓度组,MTT法检测细胞的增殖抑制率,计算半数抑制浓度(IC50),流式细胞术Annexin V/PI双染法检测细胞凋亡率,Western-blot法检测PI3K/Akt通路PI3K、Akt、p-Akt、Bcl-2蛋白的表达。结果藤茶提取物在10~50μg/mL浓度范围内对LNCaP细胞增殖抑制作用随剂量的升高而升高,IC50为28.45μg/mL;与对照组比,藤茶提取物25、50μg/mL处理组LNCaP细胞凋亡率明显升高(P<0.05,P<0.01),p-Akt、Bcl-2蛋白表达显著下调(P<0.05,P<0.01)。结论藤茶提取物对LNCaP细胞具有增殖抑制作用,其机制可能是通过抑制PI3K/Akt细胞信号通路下调Bcl-2蛋白表达从而促进凋亡。 Objective To discuss the proliferation inhibition mechanism of LNCaP cells,the human prostate cancer cells,by Tengcha extract.Methods The LNCaP cells were treated with different dosages of Tengcha extract.The MTT colorimetric method was used to detect the inhibitory effects of cell viability.The apoptosis rate was tested by the Annexin V/PI fluorescent staining of flow cytometric method.The protein expression of PI3 K,AKT,p-AKT,and Bcl-2 protein were detected by Western blot analysis.Results Between 10μg/mL and 50μg/mL,Tengcha extract could significantly inhibit LNCaP cells,with dose-dependent manner.The IC50 was 28.45μg/mL.Compared with the control group,the apoptosis rate of LNCaP cells of 25μg/mL and 50μg/mL groups were significant higher.On the contrary,the protein expression of p-Akt and Bcl-2 of them were lower obviously.All above the results had dose-dependent manner.Conclusion Tengcha extract has proliferation inhibition and apoptosis inducement with LNCaP cells.This function may be concerned with the regulation of PI3 K/Akt signal pathway and lower Bcl-2 expression.
作者 姚欣 林静瑜 郭丹 周春权 YAO Xin;LIN Jingyu;GUO Dan;ZHOU Chunquan(Fujian Academy of Tradi tional Chinene Medicine, Fuzhou, Fujian 350003, Chin)
出处 《福建医药杂志》 CAS 2018年第2期105-107,共3页 Fujian Medical Journal
基金 福建省卫生教育联合攻关计划项目 WKJ-FJ-06 福建省卫计委中医药项目(WZZE201302)
关键词 藤茶提取物 人前列腺癌LNCaP细胞 PI3K/Akt/Bcl-2 凋亡 Tengcha extract LNCaP cell PI3K/Akt/Bcl-2 apoptosis
  • 相关文献

参考文献4

二级参考文献93

  • 1姚欣,周春权,林静瑜,倪峰.复方藤茶的药理实验[J].福建中医学院学报,2007,17(6):31-33. 被引量:4
  • 2康春生,浦佩玉,李捷,王广秀.反义及显性负调节AKT2 RNA对脑胶质瘤细胞增殖抑制作用的体外研究[J].癌症,2004,23(11):1267-1272. 被引量:5
  • 3葛继荣,陈可,王和鸣.原发性骨质疏松症的中医辨证分型研究[J].福建中医学院学报,2005,15(1):9-11. 被引量:46
  • 4王宏梅,陈龙华,郑小康,李启生,伍新尧,夏云飞.抑制ATM/PI3K功能区表达对鼻咽癌细胞CNE1辐射增敏的研究[J].癌症,2006,25(9):1097-1101. 被引量:9
  • 5沈自尹 王文健.中医虚证辨证参考标准[J].中西医结合杂志,1986,6(10):598-598.
  • 6Atkins M B, Hidalgo M, Stadler W M, et al. Randomized phase Ⅱ study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma [J]. J Clin Oncol, 2004, 22(5) :909-918.
  • 7Christian T, James R, Zoran F, et al. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer : implications for therapy [ J ]. Proc Natl Acad Sci USA, 2006,103 (6) : 1888-1893.
  • 8Adachi S, Leoni L M, Carson D A, et al. Apoptosis induced by molecular targeting therapy in hematological malignancies [J]. Acta Haematol, 2004,111(1-2) : 107-123.
  • 9Campiglio M, Olgiati C, Normanno N, et al. Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 ( 'Iressa' ) is independent of EGFR expression level [J]. J Cell Physiol, 2004,198(2): 259-268.
  • 10Zhang M, Fang X, Liu H, et al. Blockade of AKT activation in prostate cancer cells with a small molecule inhibitor, 9-chIoro-2-methylellipticinium acetate (CMEP) [J]. Biochem Pharmacol, 2007,73( 1 ) : 15-24.

共引文献187

同被引文献56

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部